The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Chiome Bioscience's share price is 円113.00.
Chiome Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円12.57. Hence, Chiome Bioscience's PS Ratio for today is 8.99.
The historical rank and industry rank for Chiome Bioscience's PS Ratio or its related term are showing as below:
TSE:4583'
s PS Ratio Range Over the Past 10 Years
Min: 8.14 Med: 28.21 Max: 159.84
Current: 8.99
During the past 13 years, Chiome Bioscience's highest PS Ratio was 159.84. The lowest was 8.14. And the median was 28.21.
TSE:4583's PS Ratio is ranked worse than 50.1% of 1000
companies
in the Biotechnology industry
Industry Median: 9.055
vs TSE:4583: 8.99
Chiome Bioscience Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Chiome Bioscience was -12.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 0.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.60% per year.
During the past 13 years, Chiome Bioscience's highest 3-Year average Revenue per Share Growth Rate was 30.60% per year. The lowest was -33.40% per year. And the median was -7.10% per year.
Back to Basics: PS Ratio
Chiome Bioscience PS Ratio Historical Data
The historical data trend for Chiome Bioscience's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chiome Bioscience's PS Ratio
For the Biotechnology subindustry, Chiome Bioscience's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiome Bioscience's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chiome Bioscience's PS Ratio distribution charts can be found below:
* The bar in red indicates where Chiome Bioscience's PS Ratio falls into.
Chiome Bioscience PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Chiome Bioscience's Share Price of today is 円113.00. Chiome Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円12.57.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Chiome Bioscience PS Ratio Related Terms
Thank you for viewing the detailed overview of Chiome Bioscience's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4583 has been successfully added to your 